| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.0095 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.012 | 0.9 |